Search

Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy in patients with head and neck cancers, according to results of an MSK-led clinical trial presented today at the 2025 American Society for Radiation Oncology Annual Meeting.

… Monday, September 29, 2025 Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy (intensity modulated radiotherapy, IMRT) in patients with head and neck cancers, according to results of an MSK-led clinical trial presented

A new study from Memorial Sloan Kettering’s (MSK) Marcel van den Brink— in collaboration with Jarrod Dudakov, PhD, at the Fred Hutchinson Cancer Center — has identified a molecule that promotes thymus regeneration. The results could pave the way toward treatments that could one day help rejuvenate an aging or damaged thymus. For more information or to speak with an expert, contact Rebecca Williams at [email protected].

… Friday, January 12, 2018 Bottom line: A new study from Memorial Sloan Kettering’s (MSK) Marcel van den Brink— in collaboration with Jarrod Dudakov, PhD , at the Fred Hutchinson Cancer Center — has identified a molecule that promotes thymus regeneration. The results could pave the way toward treatments

Since its inception at MSK 10 years ago, the Immigrant Health and Cancer Disparities (IHCD) Service has made significant progress in addressing barriers to access to cancer treatment and other healthcare for underserved communities across New York City and beyond.

… Monday, April 26, 2021 Since its inception at Memorial Sloan Kettering Cancer Center 10 years ago, the Immigrant Health and Cancer Disparities (IHCD) Service has made significant progress in addressing barriers to access to cancer treatment and other healthcare for underserved communities across New

Dr. Diane Reidy-Lagunes discusses cannabis and cancer with MSK’s Director of Pediatric Integrated Medicine, Dr. Nirupa Raghunathan, and cancer survivor and winner of TV’s “Survivor: Africa”, Ethan Zohn.

… Wednesday, May 4, 2022 Cannabis is an ancient plant that has been used for rituals and medicine for 5,000 years. People with cancer have turned to cannabis — better known as weed or marijuana — to relieve effects of both the illness and the treatment. Because of its ever-changing legal status, studies

MSK has been named one of the top employers in the country, according to Forbes magazine’s 2022 list of America’s Best Large Employers. MSK placed at no. 4 out of 500 employers with more than 5,000 employees.

… Thursday, February 10, 2022 MSK has been named one of the top employers in the country, according to Forbes magazine’s 2022 list of America’s Best Large Employers. MSK placed at no. 4 out of 500 employers with more than 5,000 employees. MSK was featured on previous Forbes’ Best Employers lists but this

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.

… Wednesday, October 9, 2013 Summary Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries. This image shows a cross section of a piece of tissue that was surgically

This photo essay showcases the critical role trainees play within MSK's research enterprise.

… Tuesday, September 3, 2024 The students and postdoctoral researchers who work and train in MSK’s laboratories drive discovery forward every day. Today they are vital partners. Tomorrow they will lead further progress at hospitals, research centers, and biomedical companies around the world.   Monica

People with bladder cancer may soon have a new treatment option following surgery.

… Thursday, May 13, 2021 Update: On August 19, 2021, the US Food and Drug Administration approved nivolumab for patients with bladder cancer who are at high risk of recurrence following surgery to remove the bladder.  People whose bladder cancer has spread into the muscle wall may soon have a new treatment

Learn how rectal cancer patients with HER2 driven tumors benefited from an early stage clinical trial at MSK.

… Saturday, April 18, 2026 A clinical trial at Memorial Sloan Kettering Cancer Center (MSK) is showing promise for people with early-stage rectal cancer whose tumors are driven by excessive amounts of a protein called HER2 (human epidermal growth factor receptor 2). The trial suggests that many of these

Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR.

… Wednesday, June 6, 2012 Summary Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR. Bayard D. Clarkson, of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program